Division of Pediatric Allergy Immunology and Pulmonary Medicine

Pediatric cystic fibrosis diagnosis and treatment center honored by CF Foundation

A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.

Study finds early RSV infection linked to significantly increased risk of asthma in children

A Vanderbilt study has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children.

Paula Ciero fun toy toolkit puts children at ease during clinic visits

From fidget bracelets to sound tubes to “squishies,” Ciero finds ways to make children smile.

Study to explore nasal bacteria of children born by C-section

Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.

Javion Johnson, a patient at Children’s Hospital’s Duchenne Muscular Dystrophy Clinic, holds a plaque designating the clinic as a Certified Care Center. Others on hand include from left, his father Ronnie Johnson, mother, Xavier Verge, brother, J’zarion Williams, Andrew Sokolow, MD, Bryan Burnette, MD, Jonathan Soslow, MD, Kali Barbalena and Haleigh Southern, RN.

Vanderbilt’s Duchenne Clinic first in Tennessee to be certified

The Duchenne Muscular Dystrophy Clinic at Monroe Carell Jr. Children’s Hospital at Vanderbilt has been recognized as a Certified Duchenne Care Center Program by the Parent Project Muscular Dystrophy, and is the only center in Tennessee to receive the distinction.

International study supports dupilumab for treatment of moderate-to-severe asthma in children

In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients.

1 2